Newsroom
Must Reads
Soaring costs force cancer patients to skip drugs, treatment
John Krahne received alarming news from his doctor last December. His brain tumors were stable, but his lung tumors had grown noticeably larger.
The doctor recommended a drug called Alecensa, which sells for more than $159,000 a year. Medicare would charge Krahne a $3,200 co-pay in December, then a
Seven new ways the GOP's Obamacare repeal bill would wreck your healthcare
The headline findings in the Congressional Budget Office's analysis of the Obamacare repeal bill produced by House Republicans are brutal enough: 24 million Americans losing their health coverage, healthcare costs soaring for many millions more, and the evisceration of&
Drugmakers again boost DTC spending, to $5.6 billion in 2016
Spending on direct-to-consumer pharmaceutical ads rose 9% to $5.6 billion in 2016, in part fueled by a 16% boost in spending from Bristol-Myers Squibb, according to data from Nielsen.
Pfizer and Bristol-Myers Squibb again took the two top spots among drugmakers, spending $1.1 billion and $458 milli
Time for Nissan to walk the walk on civil rights
It was better when we first started. If I or any other worker at the Nissan plant in Canton had a workplace issue, we could discuss it with our manager and eventually it would be resolved. But along the way, things began to change. Our concerns don't matter. We’re treated like second-clas
More Must Reads
